Project · Prior
Mindleap Health
Founder & CEO
Digital platform for psychedelic preparation and integration. Founded, shipped and acquired.
- Users
- 30,000
- Acquisition
- $3.5M
- Founded to exit
- 24 mo
I founded Mindleap to close a real gap in psychedelic care: structured, accessible support for the preparation and integration work that actually determines whether the experience helps someone. The platform grew to 30,000 users in under two years. Mydecine Innovations Group, a clinical-stage biotech developing a second-generation psilocybin drug for addiction, acquired it for $3.5M, 24 months after I started the company. Mindleap is part of the track record now.
Building it, shipping it and exiting it taught me most of what I bring to the brand and systems work I do with founders today.
Mindleap is track record, not an active offering. The work of building, shipping and exiting that company sits behind the brand and systems work I do with founders today.